[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@abbvie AbbVie
AbbVie recently announced topline results from a phase 3b study on patients with moderate to severe rheumatoid arthritis, showcasing significant progress in immunology. The company also shared its Q3 2025 financial results, with the chairman and CEO highlighting outstanding results and momentum across key areas of the portfolio. Additionally, AbbVie presented new research data at various conferences, including the American College of Rheumatology and the Society of Hematologic Oncology.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +57%
- X Year XXXXXXX -XX%
Mentions: X #
- X Month XX -XX%
- X Months XXX -XX%
- X Year XXX -XX%
Followers: XXXXXX #
- X Week XXXXXX +0.01%
- X Month XXXXXX -XXXX%
- X Months XXXXXX +0.26%
- X Year XXXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks XXXXX% social networks XXXX% technology brands XXXX%
Social topic influence $abbv #17, which was 7.14%, icon XXXX%
Top accounts mentioned or mentioned by @abbvieusoncmed @binvnese2303 @genmab @stevenbaskett @robertfsiegmund @stream_rx @cwlundin1 @joshua_ryen @kelrkrug @hemonctoday @ebsummiteurope @garyselfcare @bretkerr @hepalliance @movedisorder @clladvocates @usfda @brunolarvol @ibdtweets @to_the_moon_pt
Top assets mentioned AbbVie Inc (ABBV)
Top Social Posts
Top posts by engagements in the last XX hours
"Follicular #lymphoma is a form of non-Hodgkin lymphoma that affects the lymphatic system. We look forward to convening this weekend at #ASH2025 to discuss novel therapeutic approaches for #BloodCancer patients. Learn more about our oncology focus areas:"
X Link 2025-12-05T16:00Z 79.2K followers, XXX engagements
"At #ASH25 were sharing new data on advances in therapeutic modalities for hard-to-treat blood cancers. Learn more about the data seeking to improve outcomes for patients:"
X Link 2025-12-05T22:12Z 79.2K followers, XXX engagements
"In partnership with @CLLAdvocates earlier this year we launched the Global CLL Community Insights Report which spotlighted a need for more information and resources to be shared with the #CLL community. Read the report:"
X Link 2025-12-06T15:00Z 79.2K followers, XXX engagements
"For patients like Johannes recent innovations in the treatment of #ChronicLymphocyticLeukemia (CLL) offer multiple options. Shared decision-making with healthcare providers is key to crafting tailored patient-centric therapy plans"
X Link 2025-12-08T15:00Z 79.2K followers, XXX engagements
"@kelrkrug Hi @kelrkrug we saw your tweet and would like to connect. Can you DM us with more information"
X Link 2025-12-08T17:29Z 79.2K followers, XX engagements
"NEWS: The @US_FDA has approved our medicine for the treatment of adult patients with relapsed/refractory follicular #lymphoma a form of #BloodCancer which was developed with our partner @Genmab. Read more:"
X Link 2025-11-19T19:59Z 79.2K followers, 1087 engagements
"Video description: An icon depicting a clock moving from day to night. On-screen text reads For people living with Parkinsons Disease symptoms can continue all day long"
X Link 2025-11-29T15:26Z 79.2K followers, XXX engagements
"Our team is on the ground at #ASH25 presenting new data in #hematology showcasing innovation across a range of treatment options in multiple blood cancers including #CLL. Learn more about our work:"
X Link 2025-12-08T18:00Z 79.2K followers, XXX engagements